Intravenous immunoglobulin and Guillain-Barré syndrome

scientific article published on 01 December 2005

Intravenous immunoglobulin and Guillain-Barré syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1009013634
P356DOI10.1385/CRIAI:29:3:281
P698PubMed publication ID16391403

P50authorYehuda ShoenfeldQ1515807
P2093author name stringMichal Harel
P2860cites workPractice parameter: Immunotherapy for Guillain-Barre syndrome: Report of the Quality Standards Subcommittee of the American Academy of NeurologyQ22241630
Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseasesQ33659032
Immune mediated neuropathies--an update on therapeutic strategiesQ34302018
Intravenous immune globulins in patients with Guillain-Barré syndrome and contraindications to plasma exchange: 3 days versus 6 daysQ35463309
Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of action.Q35551988
Guillain-Barré syndrome: epidemiology, pathophysiology and managementQ35690159
Intravenous immunoglobulin in autoimmune neuromuscular diseasesQ35776725
The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profileQ35832478
Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvementQ36016791
Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathiesQ40585603
Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trialQ44738594
Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degenerationQ47376638
High‐dose immunoglobulin therapy for Guillain−Barré syndrome in Japanese childrenQ53854440
Intravenous immunoglobulin therapy for Guillain-Barré syndrome with IgG anti-GM1 antibodyQ56772330
A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study GroupQ68081121
Intravenous immunoglobulin treatment in children with Guillain-Barre syndromeQ70831688
Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barré syndromeQ70894587
Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndromeQ71444464
Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial GroupQ73028007
Outcome of severe Guillain-Barré syndrome in children: comparison between untreated cases versus gamma-globulin therapyQ73206373
P433issue3
P921main subjectGuillain–Barré syndromeQ205214
P304page(s)281-287
P577publication date2005-12-01
P1433published inClinical Reviews in Allergy & ImmunologyQ1932354
P1476titleIntravenous immunoglobulin and Guillain-Barré syndrome
P478volume29

Reverse relations

cites work (P2860)
Q34117850Guillain-Barré syndrome (GBS).
Q58861212Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patients
Q37828450The strategies used for treatment of experimental autoimmune neuritis (EAN): a beneficial effect of glatiramer acetate administered intraperitoneally

Search more.